Eos SENOLYTIX, .
Eos SENOLYTIX, .33About
Eos SENOLYTIX is a longevity biotechnology company developing novel gerotherapeutics that target the fundamental mechanisms of aging. Their lead candidate, PTC-2105, utilizes proprietary MitoXcel™ Technology to restore mitochondrial function and promote the clearance of senescent cells, aiming to improve healthspan and address age-related diseases. This context-dependent approach intervenes at the root cause of aging, mitochondrial dysfunction, to drive systemic improvements.
Frequently asked
What does Eos SENOLYTIX, . do?
Eos SENOLYTIX is a longevity biotechnology company developing novel gerotherapeutics that target the fundamental mechanisms of aging. Their lead candidate, PTC-2105, utilizes proprietary MitoXcel™ Technology to restore mitochondrial function and promote the clearance of senescent cells, aiming to improve healthspan and address age-related diseases. This context-dependent approach intervenes at the root cause of aging, mitochondrial dysfunction, to drive systemic improvements.
Where is Eos SENOLYTIX, . headquartered?
Eos SENOLYTIX, . is headquartered in Cambridge, United States.
When was Eos SENOLYTIX, . founded?
Eos SENOLYTIX, . was founded in 2017.
What industry does Eos SENOLYTIX, . operate in?
Eos SENOLYTIX, . operates in Biotech, MedTech, HealthTech, Longevity, Senolytics, Drug Discovery.
Comments
No comments yet. Be the first to share your take.